110 related articles for article (PubMed ID: 14506658)
1. An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression.
Whitaker-Menezes D; Jones SC; Friedman TM; Korngold R; Murphy GF
Biol Blood Marrow Transplant; 2003 Sep; 9(9):559-70. PubMed ID: 14506658
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-host disease-related cytokine-driven apoptosis depends on p73 in cytokeratin 15-positive target cells.
Zhan Q; Korngold R; Lezcano C; McKeon F; Murphy GF
Biol Blood Marrow Transplant; 2012 Jun; 18(6):841-51. PubMed ID: 22469882
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin15-positive basal epithelial cells targeted in graft-versus-host disease express a constitutive antiapoptotic phenotype.
Zhan Q; Signoretti S; Whitaker-Menezes D; Friedman TM; Korngold R; Murphy GF
J Invest Dermatol; 2007 Jan; 127(1):106-15. PubMed ID: 17039241
[TBL] [Abstract][Full Text] [Related]
4. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
Friedman TM; Statton D; Jones SC; Berger MA; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2001; 7(1):2-13. PubMed ID: 11215694
[TBL] [Abstract][Full Text] [Related]
5. Unraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.
Fanning SL; Zilberberg J; Stein J; Vazzana K; Berger SA; Korngold R; Friedman TM
J Immunol; 2013 Jan; 190(1):447-57. PubMed ID: 23203931
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor V(alpha) usage by effector CD4+Vbeta11+ T cells mediating graft-versus-host disease directed to minor histocompatibility antigens.
DiRienzo CG; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2007 Mar; 13(3):265-76. PubMed ID: 17317580
[TBL] [Abstract][Full Text] [Related]
7. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease.
DiRienzo CG; Murphy GF; Jones SC; Korngold R; Friedman TM
Biol Blood Marrow Transplant; 2006 Aug; 12(8):818-27. PubMed ID: 16864052
[TBL] [Abstract][Full Text] [Related]
9. Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease.
Murphy GF; Sueki H; Teuscher C; Whitaker D; Korngold R
J Invest Dermatol; 1994 Apr; 102(4):451-61. PubMed ID: 7908682
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
11. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.
Friedman TM; Gilbert M; Briggs C; Korngold R
J Immunol; 1998 Jul; 161(1):41-8. PubMed ID: 9647205
[TBL] [Abstract][Full Text] [Related]
12. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation.
Miconnet I; de La Selle V; Bruley-Rosset M
Bone Marrow Transplant; 1998 Mar; 21(6):583-90. PubMed ID: 9543062
[TBL] [Abstract][Full Text] [Related]
13. Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vbeta spectratype analysis.
Zilberberg J; McElhaugh D; Gichuru LN; Korngold R; Friedman TM
J Immunol; 2008 Apr; 180(8):5352-9. PubMed ID: 18390717
[TBL] [Abstract][Full Text] [Related]
14. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
Schneider MK; Grönvik KO
Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
[TBL] [Abstract][Full Text] [Related]
15. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
[TBL] [Abstract][Full Text] [Related]
17. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
Drobyski WR; Majewski D; Ozker K; Hanson G
J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
[TBL] [Abstract][Full Text] [Related]
19. Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers.
Schilbach K; Schick J; Fluhr H; Marquordt K; Wehrmann M; Schütt BS; Schlegel PG; Niethammer D; Eyrich M
Transplantation; 2004 Jul; 78(1):31-40. PubMed ID: 15257036
[TBL] [Abstract][Full Text] [Related]
20. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
